The term C14orf131 Activators implies a class of molecules that interact with the protein encoded by the C14orf131 gene, a gene named for its position as an open reading frame on chromosome 14. The protein produced by this gene is not thoroughly characterized, and its biological functions remain largely speculative. If such a class of activators were to exist, they would be designed to modulate the activity of this protein, which could entail enhancing its expression, stabilizing the protein structure, or promoting its interaction with other cellular components. The discovery process for such activators would necessitate a foundational understanding of the protein's role within the cell, likely involving cutting-edge research techniques such as gene editing, protein expression profiling, and interaction mapping to establish the biological context of its activity. A robust functional assay that accurately reflects the activity of C14orf131 would be a prerequisite for screening potential activators, allowing researchers to sift through compound libraries to identify molecules that elicit an increase in the protein's activity.
Once initial activator candidates are identified, a rigorous process of chemical optimization would be undertaken to enhance their potency and selectivity for the C14orf131 protein. This would involve the synthesis of numerous chemical derivatives, followed by a careful evaluation of their effects on the protein's activity. Through iterative cycles of testing and modification, informed by structure-activity relationship (SAR) analysis, researchers would refine these molecules to improve their efficacy and reduce off-target effects. Advanced biophysical techniques, such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC), could be employed to gain deeper insights into the binding interactions between the activators and the C14orf131 protein. The ultimate aim of this research would be to develop a collection of precise molecular tools to regulate the activity of C14orf131, providing a clearer understanding of its function and its contribution to the complex network of cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression during cell differentiation, which may influence ZNF839 expression as it could be involved in such processes. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor that can cause demethylation of gene promoter regions, possibly leading to increased ZNF839 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, Trichostatin A can alter chromatin structure and affect the expression of various genes, potentially including ZNF839. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate serves as an HDAC inhibitor and could upregulate genes like ZNF839 through epigenetic modifications. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin induces ER stress and the unfolded protein response, which can alter gene expression, potentially affecting ZNF839. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is another ER stress inducer that might modify the expression of genes such as ZNF839 as part of the stress response. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium may modulate GSK-3β activity and Wnt signaling, pathways that can influence gene expression, including ZNF839. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPARγ agonist, rosiglitazone can influence the expression of genes involved in adipogenesis, which might include ZNF839. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which could affect gene expression, potentially influencing ZNF839 expression levels. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a hormone that regulates gene expression, β-estradiol might have an impact on the expression of ZNF839 in hormone-responsive tissues. | ||||||